Paul Keel assumed the role of President & CEO at Envista Holdings Corp on May 1, 2024, bringing with him a wealth of experience and a proven track record in leadership within the healthcare and technology sectors. Prior to joining Envista, Keel served as the President and CEO of Smiths Medical, a global provider of medical devices and equipment, where he successfully led the company through a period of significant growth and transformation. Under his leadership, Smiths Medical expanded its product portfolio and enhanced its market presence, demonstrating Keel's strategic vision and operational expertise. Before his tenure at Smiths Medical, Keel held various executive positions at other prominent companies, including Covidien and Johnson & Johnson. At Covidien, he was instrumental in driving the company's respiratory and monitoring solutions business, while at Johnson & Johnson, he played a key role in the development and commercialization of innovative medical technologies. Keel's career is marked by his ability to foster innovation, build high-performing teams, and deliver sustainable growth, making him an ideal fit for Envista Holdings Corp. As President & CEO of Envista Holdings Corp, Paul Keel is tasked with steering the company towards continued success in the dental products and technologies market. His strategic focus includes enhancing Envista's product offerings, expanding its global footprint, and leveraging technology to improve patient outcomes. With his extensive experience and leadership skills, Keel is well-positioned to guide Envista through the evolving landscape of the dental industry, ensuring the company remains at the forefront of innovation and service excellence.